Thomas Pilgrim

Showing 1-20 of 20 articles

Coronary interventions

Validation of Bleeding Risk Criteria (ARC-HBR) in Patients Undergoing Percutaneous Coronary Intervention and Comparison with Contemporary Bleeding Risk Scores

Ueki Y, Bär S, Losdat S, Otsuka T, Zanchin C, Zanchin T, Gragnano F, Gargiulo G, Siontis G, Praz F, Lanz J, Hunziker L, Stortecky S, Pilgrim T, Heg D, Valgimigli M, Windecker S, Räber L

February 18, 2020 | 10.4244/EIJ-D-20-00052

Interventions for valvular disease

Feasibility and safety of transcaval transcatheter aortic valve implantation: a multicentre European registry

Costa G, De Backer O, Pilgrim T, Kasel A, Redwood S, Aminian A, Lanz J, Michel J, Patterson T, Windecker S, Prendergast B, Greenbaum A, Søndergaard L

February 7, 2020 | 10.4244/EIJ-D-19-00797

Optimal fluoroscopic viewing angles of right-sided heart structures in patients with tricuspid regurgitation based on multislice computed tomography

Xiong T, Pighi M, Thériault-Lauzier P, Leipsic J, Spaziano M, Martucci G, Buithieu J, Mousavi N, Pilgrim T, Praz F, Windecker S, Chen M, Piazza N

November 15, 2019 | 10.4244/EIJ-D-19-00618

Interventions for valvular disease

Bioprosthetic Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA) during transcatheter aortic valve-in-valve implantation with bioprosthetic valve fracturing via the transcaval access

Lanz J, Pilgrim T, Greenbaum A, Windecker S

October 19, 2018 | 10.4244/EIJ-D-18-00553

Current state of alternative access for transcatheter aortic valve implantation

Lanz J, Greenbaum A, Pilgrim T, Tarantini G, Windecker S

September 7, 2018 | 10.4244/EIJ-D-18-00552

A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial

Iglesias JF, Mueller O, Zaugg S, Roffi M, Kurz D, Vuilliomenet A, Weilenmann D, Kaiser C, Tapponnier M, Heg D, Valgimigli M, Eeckhout E, Jüni P, Windecker S, Pilgrim T

August 24, 2018 | 10.4244/EIJ-D-17-00734

Interventions for valvular disease

Prognostic impact of invasive haemodynamic measurements in combination with clinical and echocardiographic characteristics on two-year clinical outcomes of patients undergoing transcatheter aortic valve implantation

Franzone A, O’Sullivan C, Stortecky S, Heg D, Lanz J, Vollenbroich R, Praz F, Piccolo R, Asami M, Roost E, Räber L, Valgimigli M, Windecker S, Pilgrim T

April 7, 2017 | 10.4244/EIJ-D-16-00790

Coronary interventions

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction

Pilgrim T, Piccolo R, Heg D, Roffi M, Tüller D, Vuilliomenet A, Mueller O, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Khattab A, Taniwaki M, Rigamonti F, Nietlispach F, Blochlinger S, Wenaweser P, Jüni P, Windecker S

December 9, 2016 | 10.4244/EIJY15M12_09

Coronary interventions

External validity of a contemporaneous primary percutaneous coronary intervention trial in patients with acute ST-elevation myocardial infarction: insights from a single-centre investigation

Spitzer E, Hadorn S, Zanchin T, Yamaji K, Moschovitis A, Pilgrim T, Stortecky S, Jüni P, Heg D, Windecker S, Räber L

October 20, 2016 | 10.4244/EIJV12I9A185

Interventions for valvular disease

Bilateral, reversible coronary obstruction during aortic valve-in-valve implantation of a repositionable valve system

Praz F, Moschovitis A, Stortecky S, Pilgrim T, Eberle B, Windecker S

October 20, 2016 | 10.4244/EIJV12I9A194

Coronary interventions

Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trial

Franzone A, Taniwaki M, Rigamonti F, Heg D, Piccolo R, Roffi M, Tüller D, Mueller O, Vuilliomenet A, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Jüni P, Windecker S, Pilgrim T

August 5, 2016 | 10.4244/EIJV12I5A99

Coronary interventions

Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study

Räber L, Onuma Y, Brugaletta S, Garcia-Garcia H, Backx B, Iñiguez A, Okkels Jensen L, Cequier-Fillat A, Pilgrim T, Christiansen E, Hofma S, Suttorp M, Serruys P, Sabate M, Windecker S

July 20, 2016 | 10.4244/EIJY15M08_03

Interventions for valvular disease

Effect of resting heart rate on two-year clinical outcomes of high-risk patients with severe symptomatic aortic stenosis undergoing transcatheter aortic valve implantation

O’Sullivan C, Spitzer E, Heg D, Praz F, Stortecky S, Huber C, Carrel T, Pilgrim T, Windecker S

July 20, 2016 | 10.4244/EIJV12I4A83

Will this trial change my practice? ABSORB II trial (a bioresorbable vascular scaffold versus drug-eluting stent in coronary disease)

De Palma R, Byrne R, van Geuns R, Pilgrim T, Jüni P, Al Rashdan I

July 20, 2015 | 10.4244/EIJV11I3A72

Five-year results of a randomised comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularisation

Pilgrim T, Räber L, Limacher A, Wenaweser P, Cook S, Stauffer J-C, Garachemani A, Moschovitis A, Meier B, Jüni P, Windecker S

March 20, 2015 | 10.4244/EIJY15M01_04

Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents

O’Sullivan C, Stefanini G, Räber L, Heg D, Taniwaki M, Kalesan B, Pilgrim T, Zanchin T, Moschovitis A, Büllesfeld L, Khattab A, Meier B, Wenaweser P, Jüni P, Windecker S

January 20, 2014 | 10.4244/EIJV9I9A182

Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents

Pilgrim T, Kalesan B, Zanchin T, Pulver C, Jung S, Mattle H, Carrel T, Moschovitis A, Stortecky S, Wenaweser P, Stefanini G, Räber L, Meier B, Jüni P, Windecker S

January 18, 2013 | 10.4244/EIJV8I9A163

Improvement of physical and mental health after transfemoral transcatheter aortic valve implantation

Stortecky S, Schmid V, Windecker S, Kadner A, Pilgrim T, Buellesfeld L, Khattab A, Wenaweser P

August 24, 2012 | 10.4244/EIJV8I4A69

Cerebrovascular accidents complicating transcatheter aortic valve implantation: frequency, timing and impact on outcomes

Stortecky S, Windecker S, Pilgrim T, Heg D, Buellesfeld L, Khattab A, Huber C, Gloekler S, Nietlispach F, Mattle H, Jüni P, Wenaweser P

May 15, 2012 | 10.4244/EIJV8I1A11

Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation

Wenaweser P, Pilgrim T, Guérios E, Stortecky S, Huber C, Khattab A, Kadner A, Buellesfeld L, Gloekler S, Meier B, Carrel T, Windecker S

September 30, 2011 | 10.4244/EIJV7I5A89

Latest news

NEW ISSUE

PCR e-Course; LM interventions; FFR and STEMI, the EAPCI and COVID-19; TMVR

June 25, 2020

NEW

Ahead of print: EAPCI Core Curriculum for PCI (2020)

July 7, 2020

Editorial

IVUS guidance during left main PCI: not if, but when and how

Akiko Maehara

July 8, 2020

NEW

Ahead of print: EAPCI Expert Consensus Document: Ischaemia with non-obstructive coronary arteries

V. Kunadian et al

July 6, 2020

Editorial

Left main PCI: are we giving the kiss the attention it deserves?

July 8, 2020

Find the latest trials:

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

July 1, 2020

JAA

This Week's JAA's: CULPRIT-SHOCK substudy, Coronary Microcatheter Complications...

Thomas Pilgrim

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke